相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
Jooeun Bae et al.
LEUKEMIA (2022)
PKCα/JZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma
Chuan-Yuan Wei et al.
JOURNAL OF HEPATOLOGY (2022)
Tuning T cell receptor sensitivity through catch bond engineering
Xiang Zhao et al.
SCIENCE (2022)
Transcriptome analysis of Homo sapiens and Mus musculus reveals mechanisms of CD8+T cell exhaustion caused by different factors
Lin Zhang et al.
PLOS ONE (2022)
Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy
Mi Jeong Kim et al.
CANCER BIOLOGY & THERAPY (2021)
The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity
Fan Zou et al.
MOLECULAR THERAPY (2021)
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E. Scharping et al.
NATURE IMMUNOLOGY (2021)
Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer
Marina Martinez et al.
ONCOIMMUNOLOGY (2021)
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
Christian Sordo-Bahamonde et al.
CANCERS (2021)
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC
Chenhe Yi et al.
HEPATOLOGY (2021)
Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy
Zhisong Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
Suresh Gopi Kalathil et al.
CELLS (2021)
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma
Kohei Shigeta et al.
HEPATOLOGY (2020)
The emerging role of epigenetic therapeutics in immuno-oncology
Michael J. Topper et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang et al.
CLINICAL CANCER RESEARCH (2020)
Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
Guolong Xu et al.
ONCOGENE (2020)
Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer
Kazuo Okadome et al.
ANNALS OF SURGERY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Maria Esperanza Rodriguez-Ruiz et al.
NATURE IMMUNOLOGY (2020)
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma
Sai Arun Batra et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice
David Kung-Chun Chiu et al.
GASTROENTEROLOGY (2020)
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
Jan A. Rath et al.
CELLS (2020)
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Analysis of single-cell RNAseq identifies transitional states of T cells associated with hepatocellular carcinoma
Yanying Yang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients
Dan Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Tamas A. Gonda et al.
CANCER RESEARCH (2020)
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Ivan Marquez-Rodas et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer
Allison S. Cohen et al.
TRANSLATIONAL ONCOLOGY (2020)
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Thomas Yau et al.
JAMA ONCOLOGY (2020)
Exhausted T cells and epigenetic status
Ziqing Zeng et al.
CANCER BIOLOGY & MEDICINE (2020)
Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
Long Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines
Mathias Vormehr et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Michael Teufel et al.
GASTROENTEROLOGY (2019)
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing et al.
IMMUNITY (2019)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C. Miller et al.
NATURE IMMUNOLOGY (2019)
A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Hagma H. Workel et al.
CANCER IMMUNOLOGY RESEARCH (2019)
A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
Elizabeth K. Duperret et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Mehrdad Rakaee et al.
NEOPLASIA (2019)
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane et al.
Annual Review of Immunology (2019)
Induction of tolerogenic dendritic cells by activated TGF-/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells
Ming Zhong et al.
BMC CANCER (2019)
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
Urania Dafni et al.
LUNG CANCER (2019)
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Jun Sik Yoon et al.
BMC CANCER (2019)
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Francesca Alfei et al.
NATURE (2019)
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew C. Scott et al.
NATURE (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Claire Vanpouille-Box et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
Sourav Paul et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Diana Llopiz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer
Zhen Tao et al.
CLINICAL CANCER RESEARCH (2019)
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells
Sema Kurtulus et al.
IMMUNITY (2019)
Ecto-5-nucleotidase (CD73) is a potential target of hepatocellular carcinoma
Shalaimaiti Shali et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection
William H. Hudson et al.
IMMUNITY (2019)
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation
Nadja Blagitko-Dorfs et al.
LEUKEMIA (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
c-Jun overexpression in CAR T cells induces exhaustion resistance
Rachel C. Lynn et al.
NATURE (2019)
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma
Shailender Bhatia et al.
CLINICAL CANCER RESEARCH (2019)
Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells
Yu-Qing Xie et al.
BIOMATERIALS SCIENCE (2019)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment
Takuya Kato et al.
CLINICAL CANCER RESEARCH (2018)
PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model
Rui Deng et al.
HEMATOLOGY (2018)
Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
Jian-Feng Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway
Ang Li et al.
ONCOGENE (2018)
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel et al.
SCIENCE (2018)
CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer
Shengbo Zhang et al.
CELL DEATH & DISEASE (2018)
NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion
Liwen Li et al.
ONCOIMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Evolutionary Pressure against MHC Class II Binding Cancer Mutations
Rachel Marty et al.
CELL (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman et al.
CELL (2018)
Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection
Tomohiro Okagawa et al.
VETERINARY RESEARCH (2018)
Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy
David Gyori et al.
JCI INSIGHT (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma
Lei Chen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells
Judith F. Ashouri et al.
JOURNAL OF IMMUNOLOGY (2017)
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Guoying Zhou et al.
GASTROENTEROLOGY (2017)
Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection
Kevin Man et al.
IMMUNITY (2017)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
Wenwen Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Cutting Edge: Chromatin Accessibility Programs CD8 T Cell Memory
Christopher D. Scharer et al.
JOURNAL OF IMMUNOLOGY (2017)
T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
Jian-Feng Liu et al.
MOLECULAR ONCOLOGY (2017)
Effector CD8 T cells dedifferentiate into long-lived memory cells
Ben Youngblood et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells
Giuliana P. Mognol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications
Masato Nakajima et al.
TUMOR BIOLOGY (2017)
Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
M. Fehlings et al.
NATURE COMMUNICATIONS (2017)
PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression
Philippe Foubert et al.
CANCER IMMUNOLOGY RESEARCH (2017)
EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity
Diana I. Albu et al.
ONCOIMMUNOLOGY (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
Cathrin Ritter et al.
SCIENTIFIC REPORTS (2017)
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Michael J. Topper et al.
CELL (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Hazem E. Ghoneim et al.
CELL (2017)
Developments in cancer vaccines for hepatocellular carcinoma
Luigi Buonaguro
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses (vol 152, pg 974, 2015)
Katherine B. Chiappinelli et al.
CELL (2016)
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Hong Zheng et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
Andrea Schietinger et al.
IMMUNITY (2016)
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors
Zinal S. Chheda et al.
JOURNAL OF IMMUNOLOGY (2016)
Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma
Zhu Li et al.
MEDICINE (2016)
The epigenetic landscape of T cell exhaustion
Debattama R. Sen et al.
SCIENCE (2016)
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Kristen E. Pauken et al.
SCIENCE (2016)
TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype
Fan Zhang et al.
ONCOTARGET (2016)
TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies
Tristan Courau et al.
JCI INSIGHT (2016)
Tumor-infiltrating lymphocyte activity is enhanced in tumors with low IL-10 production in HBV-induced hepatocellular carcinoma
Yang Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
Maria Tagliamonte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8+ T Cells
Gustavo J. Martinez et al.
IMMUNITY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
Timothy J. Zumwalt et al.
ONCOTARGET (2015)
A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
Shan-Shan Jiang et al.
ONCOTARGET (2015)
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Clinical blockade of PD1 and LAG3-potential mechanisms of action
Linh T. Nguyen et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Heterogeneity in the Differentiation and Function of CD8+ T Cells
Hans-Willi Mittruecker et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
Matthew M. Staron et al.
IMMUNITY (2014)
Transforming Growth Factor β-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression
Tom L. Stephen et al.
IMMUNITY (2014)
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Netanya G. Sandler et al.
NATURE (2014)
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Andrea Schietinger et al.
TRENDS IN IMMUNOLOGY (2014)
Tumor cell lysates as immunogenic sources for cancer vaccine design
Fermin E. Gonzalez et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Chemotherapy and oncoyic virotherapy: advanced tactics in the war against cancer
Andrew Nguyen et al.
FRONTIERS IN ONCOLOGY (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
T cell responses: naive to memory and everything in between
Nathan D. Pennock et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2013)
Role of regulatory T cells during virus infection
Tamara Veiga-Parga et al.
IMMUNOLOGICAL REVIEWS (2013)
Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments
I-Cheng Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner
Yong Yi et al.
JOURNAL OF HEPATOLOGY (2013)
Technical Advance: Fluorescent reporter reveals insights into eomesodermin biology in cytotoxic lymphocytes
Michael A. Paley et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
Andrew L. Doedens et al.
NATURE IMMUNOLOGY (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
John R. Teijaro et al.
SCIENCE (2013)
Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
Brian J. Cameron et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Programmed Cell Death 1-Directed Immunotherapy for Enhancing T-Cell Function
Koichi Araki et al.
IMMUNITY AND TOLERANCE (2013)
The integration of T cell migration, differentiation and function
David Masopust et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8+ T Cell Exhaustion versus Memory
Travis A. Doering et al.
IMMUNITY (2012)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
Tadashi Yokosuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Progressive Loss of Memory T Cell Potential and Commitment to Exhaustion during Chronic Viral Infection
Jill M. Angelosanto et al.
JOURNAL OF VIROLOGY (2012)
Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
Michael A. Paley et al.
SCIENCE (2012)
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Elisabetta Fratta et al.
MOLECULAR ONCOLOGY (2011)
Adoptive cellular therapy enhances the helper T cell response and reduces the number of regulatory T cells
Takeshi Ishikawa et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
Reciprocal responsiveness to interleukin-12 and interferon-α specifies human CD8+ effector versus central memory T-cell fates
Hilario J. Ramos et al.
BLOOD (2009)
Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell
Yeh C. Linn et al.
IMMUNOLOGY (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression
Sheng Xiao et al.
JOURNAL OF IMMUNOLOGY (2008)
Glucose uptake is limiting in T cell activation and requires CD28-mediated akt-dependent and independent pathways
Sarah R. Jacobs et al.
JOURNAL OF IMMUNOLOGY (2008)
Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity
S. Miura et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells
Andrew M. Intlekofer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
TGF-β1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells
M Ahmadzadeh et al.
JOURNAL OF IMMUNOLOGY (2005)
A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood
S Yamagiwa et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
